In 2021, the Board held five regular meetings and 12 special meetings. The independent directors met 11 times in executive session without management present. Each director attended 93% or more of the total number of meetings of the Board and his or her respective committees (for the period that such director served on the Board and/or committee during 2021); overall attendance at such meetings was over 98%. While the Company does not have a formal policy on director attendance at annual meetings, it strongly encourages its directors to attend the annual meeting of the shareholders. All directors attended the Company’s 2021 Annual Meeting of Shareholders, which was held via live webcast in a virtual meeting format.

The Board has four standing Committees: Audit, Management Development and Compensation, Corporate Governance, and Public Policy and Corporate Responsibility. The responsibilities of each standing committee are set forth in a written charter. Committee charters are reviewed annually by the Corporate Governance Committee and the Board. The Board may form new committees, disband existing committees, and delegate additional responsibilities to a committee. All standing committee charters are available on the Company’s investor relations website at

Audit Committee Management Development and Compensation Committee Corporate Governance Committee Public Policy and Corporate Responsibility Committee
Lydia I. Beebe
Lee M. Canaan
Janet L. Carrig
Frank C. Hu
Dr. Kathryn J. Jackson
John McCartney
James T. McManus II
Anita M. Powers
Daniel J. Rice, IV
Hallie A. Vanderhider
  • Board Chair
  • Committee Member
  • Committee Chair